Jeanne H Schickli et al.
The Journal of clinical investigation, 125(4), 1637-1647 (2015-03-10)
Respiratory syncytial virus (RSV) is the most common cause of serious viral bronchiolitis in infants, young children, and the elderly. Currently, there is not an FDA-approved vaccine available for RSV, though the mAb palivizumab is licensed to reduce the incidence